3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
13
Genitourinary
7
Other hematologic neoplasm
5
Gynecologic
3
Breast
3
Lymphoid
2
Head & Neck
2
Plasma cell
1
Other
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Lymphoma
306
Lymphoma, Follicular
268
Lymphoma, Non-Hodgkin
170
Leukemia
138
Hodgkin Disease
135
Multiple Myeloma
130
Leukemia, Lymphocytic, Chronic, B-Cell
110
Lymphoma, Large B-Cell, Diffuse
108
Leukemia, Myeloid, Acute
98
Neoplasms
83
Lymphoma, Mantle-Cell
70
Burkitt Lymphoma
70
Myelodysplastic Syndromes
64
Breast Neoplasms
62
Lymphoma, T-Cell, Cutaneous
60
Lymphoma, B-Cell, Marginal Zone
59
Myeloproliferative Disorders
50
Mycosis Fungoides
50
Motor Activity
49
Lymphoma, Large-Cell, Immunoblastic
47
Sezary Syndrome
44
Neoplasms, Plasma Cell
42
Hematologic Neoplasms
41
Dementia
41
Primary Myelofibrosis
39
Leukemia, Myeloid, Chronic-Phase
38
Leukemia, Myeloid, Accelerated Phase
38
Congenital Abnormalities
38
Recurrence
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Frailty
×
Lymphoid
×
Clear all
NCT06379282
2024-04-24
HIT-CLL
University of Surrey
Phase NA
Recruiting
132 enrolled
NCT05343611
2023-06-23
Choko-AGE
Universita di Verona
Phase NA
Unknown
102 enrolled